Table 5.
n | HR (95% CI) | P | |
---|---|---|---|
Male subjects | 7925 | ||
IFG (−) | |||
T1 | 2390 | Reference | - |
T2 | 2203 | 1.69 (1.06–2.68) | 0.026 |
T3 | 1952 | 3.99 (2.63–6.04) | < 0.001 |
IFG (+) | |||
T1 | 248 | 12.8 (7.74–21.2) | < 0.001 |
T2 | 442 | 16.6 (10.8–25.6) | < 0.001 |
T3 | 690 | 30.0 (20.2–44.6) | < 0.001 |
Female subjects | 4365 | ||
IFG (−) | |||
T1 | 1430 | Reference | – |
T2 | 1391 | 1.19 (0.60–2.39) | 0.618 |
T3 | 1270 | 2.19 (1.16–4.14) | 0.016 |
IFG (+) | |||
T1 | 28 | 9.51 (2.72–33.2) | < 0.001 |
T2 | 64 | 12.9 (5.61–29.4) | < 0.001 |
T3 | 182 | 25.7 (13.7–48.1) | < 0.001 |
CI confidence interval, DM diabetes mellitus, FLI fatty liver index, HR hazard ratio, IFG impaired fasting glucose.
IFG was defined as fasting plasma glucose ≥ 100 mg/dL.
The model was adjusted for age, smoking habit, alcohol drinking habit, family history of DM, hypertension and dyslipidemia.